Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 500 of 2873 entries
View as:

Interactive Voice Response System in Advanced Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00625638 Org: User:
Start: 01/28/08 End: 12/02/22 Due: 12/02/23

Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides

Phase: N/A Priority: Normal
NCT ID: NCT01073267 Org: User:
Start: 02/28/10 End: 12/31/14 Due: 12/31/15

Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00081159 Org: User:
Start: 07/31/04 End: 09/30/14 Due: 09/30/15

Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States

Phase: N/A Priority: Normal
NCT ID: NCT00038779 Org: User:
Start: 08/14/96 End: 09/20/04 Due: 09/20/05

Subcutaneous Olanzapine for Hyperactive or Mixed Delirium

Phase: N/A Priority: Normal
NCT ID: NCT00512291 Org: User:
Start: 06/30/05 End: 08/31/09 Due: 08/31/10

Virtual Reality Intervention in Cancer Genetics

Phase: N/A Priority: Normal
NCT ID: NCT01310829 Org: User:
Start: 02/28/11 End: 05/31/16 Due: 05/31/17

Group Therapy for Nicotine Dependence: Mindfulness and Smoking

Phase: N/A Priority: Normal
NCT ID: NCT00297479 Org: User:
Start: 04/30/05 End: 09/30/16 Due: 09/30/17

Single-arm Study With Bimiralisib in Patients With HNSCC Harboring NOTCH1 Loss of Function Mutations

Phase: N/A Priority: Normal
NCT ID: NCT03740100 Org: User:
Start: 01/25/19 End: 12/09/20 Due: 12/09/21

Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies

Phase: N/A Priority: Normal
NCT ID: NCT03099850 Org: User:
Start: 04/01/21 End: 02/02/27 Due: 02/02/28

Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia

Phase: N/A Priority: Normal
NCT ID: NCT00513123 Org: User:
Start: 09/30/02 End: 02/28/09 Due: 02/28/10

A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation

Phase: N/A Priority: Normal
NCT ID: NCT00667888 Org: User:
Start: 01/03/01 End: 10/31/21 Due: 10/31/22

Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05071677 Org: User:
Start: 05/03/21 End: 08/07/23 Due: 08/07/24

The ATTAIN Study: A Therapeutic Trial of Afatinib In the Neoadjuvant Setting

Phase: N/A Priority: Normal
NCT ID: NCT02271906 Org: User:
Start: 07/01/15 End: 08/16/17 Due: 08/16/18

Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT00414310 Org: User:
Start: 12/31/06 End: 05/31/15 Due: 05/31/16

Clearance Of Mucus In Stents (COMIS)

Phase: N/A Priority: Normal
NCT ID: NCT01370278 Org: User:
Start: 06/16/11 End: 08/23/23 Due: 08/23/24

Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03047993 Org: User:
Start: 11/15/17 End: 03/16/23 Due: 03/16/24

A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06930651 Org: User:
Start: 10/01/25 End: 05/01/30 Due: 05/01/31

Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01793051 Org: User:
Start: 03/22/13 End: 09/18/20 Due: 09/18/21

Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00479089 Org: User:
Start: 02/29/04 End: 08/31/14 Due: 08/31/15

AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin

Phase: N/A Priority: Normal
NCT ID: NCT00147225 Org: User:
Start: 08/31/05 End: 03/31/13 Due: 03/31/14

Supporting Informed Decision Making About Multi-cancer Early Detection Testing

Phase: N/A Priority: Normal
NCT ID: NCT06870916 Org: User:
Start: 03/07/25 End: 01/01/27 Due: 01/01/28

Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin

Phase: N/A Priority: Normal
NCT ID: NCT00430313 Org: User:
Start: 01/04/07 End: 08/10/22 Due: 08/10/23

Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01176604 Org: User:
Start: 08/04/10 End: 04/09/21 Due: 04/09/22

Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan

Phase: N/A Priority: Normal
NCT ID: NCT00496873 Org: User:
Start: 06/30/05 End: 12/31/14 Due: 12/31/15

Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT00038441 Org: User:
Start: 09/30/95 End: 08/31/05 Due: 08/31/06